Behnam Nabet, ’15 PhD, who just completed his doctorate in the Driskill Graduate Program in Life Sciences, studied how mutated Ras genes turn normal cells into cancer cells in a new publication.
Northwestern Medicine scientists have discovered how a gene linked to leukemia functions, a finding that may have important implications for children with Down syndrome who have a higher risk of developing the blood cancer.
A study coauthored by Northwestern Medicine scientists found that normal cells stop proliferating when they lose important intracellular structures called centrioles, but cancer cells continue to multiply.
Medical Scientist Training Program students and twin sisters Lauren Smith, ’15 PhD, and Adrienne Long, ’15 PhD, discuss their recently published research projects and their futures as physician-scientists.
A new study suggests a toxin responsible for seafood-associated sepsis and necrotizing fasciitis may have the ability to treat cancer by destroying the protein Ras.
The impossible is possible when cancer survivors are monitored by medical professionals who know their specialized needs.
A distinct pattern in the changing lengths of telomeres years before cancer diagnoses could yield a new biomarker that predict cancer, according to a new study.
David Gius, MD, PhD, professor in Radiation Oncology and Pharmacology, collaborated with University of Chicago scientists on a study identifying a natural compound that activates the protein SIRT3, a potential target for breast cancer, cardiac conditions and other diseases.
The majority of children who survive cancer in the U.S. face chronic health problems related to their treatment, according to a new Northwestern Medicine study.
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM) when delivered using spherical nucleic acid nanoparticles.